Rocket Pharmaceuticals, Inc. · NASDAQ:RCKT
Shah Gaurav sold 3,020 Rocket Pharmaceuticals, Inc. shares (Form 4)
Traded Nov 13, 2026 · Filed Nov 17, 2026
On Nov 13, 2026, Shah Gaurav (CEO) sold 3,020 Rocket Pharmaceuticals, Inc. shares at US$2.25 for US$6,795, leaving 1,053,574 shares. Filed Nov 17, 2026 (Form 4).
- Sold
- 3,020 shares
- Price
- US$2.25
- Value
- US$6,795
- Holding after
- 1,053,574 shares
- Trading plan
- No
- Role
- CEO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Nov 13, 2026 | Common Stock | Sale | 3,020 | US$2.25 | 1,053,574 | Direct |
Source
Download original · View original at SEC
Related
- Rocket Pharmaceuticals, Inc.
- Shah Gaurav
- Rocket Pharmaceuticals, Inc. shareholders
- Form 4 · Shah Gaurav · Nov 20, 2026
- Form 4 · Shah Gaurav · Aug 20, 2026
- Form 4 · Shah Gaurav · Aug 17, 2026
- Form 4 · Shah Gaurav · May 26, 2026
- Form 4 · Shah Gaurav · May 21, 2026
- Form 4 · Wilson Martin · Nov 20, 2026
- Form 4 · Wilson Martin · Nov 17, 2026
- Form 4 · Chaudhuri Sarbani · Nov 12, 2026
- Form 4 · Wilson Martin · Nov 9, 2026
- Schedule 13G/A · Vanguard Portfolio Management LLC · Oct 30, 2026